clinical-trial – Page 7

FDA approves a new drug for symptoms of Huntington's disease

Deutetrabenazine becomes the first new drug in a decade licensed by the FDA for symptoms of Huntington's disease

April 5, 2017

Pfizer announces the 'Amaryllis' trial of a PDE-10 inhibitor drug failed to improve symptoms of HD

December 16, 2016

HDBuzz helps untangle some bold claims about the just-announced results of the PRIDE-HD trial of pridopidine in HD

September 30, 2016

HDBuzz summarizes the science from an unusually large and energized @HDSA convention in Baltimore

June 13, 2016

HD reaches more brain structures than we thought: new research broadens our understanding of the earliest signs of HD

April 18, 2016

A confusing story about a huntingtin lowering trial is published in the Telegraph, but cool new stuff is happening!

March 10, 2016

Strategies for getting rid of mutant huntingtin & clinical trial updates: day 2 of the HD therapeutics conference

February 25, 2016

Phase 2/3 clinical trial results prove inconclusive for Huntington's drug cysteamine.

December 18, 2015

Major Announcement: First HD patients treated with gene silencing drugs

October 19, 2015

HDBuzz untangles hope from hype in clinical trial announcements

October 9, 2015